Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer
02 November 2023 - 7:06AM
Business Wire
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin
delivery and diabetes technology company, today announced the
appointment of Mark Novara as Executive Vice President and Chief
Commercial Officer, effective November 13, 2023. Mr. Novara comes
to Tandem with extensive global healthcare experience, having
served in the diabetes, medical technology, and life sciences
industries for nearly 25 years.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20231101343981/en/
Mark Novara (Photo: Business Wire)
“Mark is a strategic, global leader with a successful track
record of driving above market business growth, while building
scalable commercial operations and delivering best-in-class
customer experience,” said John Sheridan, president and CEO. “We
welcome Mark to our leadership team at this exciting stage in
Tandem’s evolution, as we prepare to expand our family of
innovative technologies and execute on our shared vision to improve
the lives of people with diabetes.”
“I was drawn to Tandem’s mission-driven commitment to innovation
and their customer-centric culture,” said Mr. Novara. “Tandem has a
strong portfolio powered by Control-IQ technology that provides
compelling clinical results for people living with diabetes. I am
excited to be joining Tandem at this pivotal time and look forward
to working closely with the team to build on its strong foundation
through new product launches, commercial excellence and global
expansion.”
Mr. Novara joins Tandem Diabetes Care from McKinsey &
Company, where he served as Senior Advisor in the Medical
Technology/Life Science practice since February 2023. Before that
time, Mr. Novara held executive positions at Becton Dickinson for
more than a decade, most recently serving as Worldwide Vice
President and General Manager in Medication Delivery Solutions, as
Senior Vice President, Global Strategic Marketing for the Medical
and Life Sciences Segments, and as Worldwide Vice President and
General Manager in Diabetes Care. He also held leadership positions
with Roche and Sanofi-Aventis. Mr. Novara received a BS in Biology
from Villanova University, and a Masters in Healthcare Management
from Columbia University.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc., a global insulin delivery and
diabetes technology company based in San Diego, California, creates
new possibilities for people living with diabetes, their loved
ones, and healthcare providers through a positively different
experience. The company’s human-centered approach to design,
development, and support delivers innovative products and services
for people who use insulin. Tandem manufactures and sells the
t:slim X2 pump with Control-IQ technology. For more information,
visit tandemdiabetes.com.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use
#tslimX2 and #TandemDiabetes. Follow Tandem Diabetes Care on
Facebook at facebook.com/TandemDiabetes. Follow Tandem Diabetes
Care on LinkedIn at linkedin.com/company/tandemdiabetes.
© 2023 Tandem Diabetes Care, Inc. All rights reserved. Tandem
Diabetes Care, the Tandem logo, Control-IQ, Tandem Mobi and t:slim
X2 are either registered trademarks or trademarks of Tandem
Diabetes Care, Inc. in the United States and/or other countries.
All third-party marks are the property of their respective
owners.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231101343981/en/
Media Contact: 858-255-6388 media@tandemdiabetes.com
Investor Contact: 858-366-6900 IR@tandemdiabetes.com
Tandem Diabetes Care (NASDAQ:TNDM)
Historical Stock Chart
From Apr 2024 to May 2024
Tandem Diabetes Care (NASDAQ:TNDM)
Historical Stock Chart
From May 2023 to May 2024